Similarly, expression of the PERK pathway down-stream targets ATF4 and CHOP was negatively correlated with survival (Fig. 3d–e) and CHOP expression was elevated in melanoma compared to nevi samples (Fig. 3f). The gene discussed is EIF2AK3; the disease is melanoma.